Castle Harlan Wins “Deal of the Year” Award from ACG Houston
The private equity firm was awarded for its acquisition of Exterran Corporation's oil and gas production equipment assets.
Recent Deals
Sentinel Midstream Announces New Deepwater Crude Oil Export Facility
The facility, backed by middle-market energy investor Cresta Fund Management, will be capable of loading one "supertanker" per day.
Redwood Logistics Joining Forces With Strive Logistics
Strive was acquired by Redwood, a portfolio company of middle-market private equity firm CI Capital.
TMP Worldwide Announces Acquisition of CKR Interactive
TMP, an employee recruitment software maker and Gemspring Capital portfolio company, recently acquired marketing firm CKR.
Critical Alert Systems to Acquire Sphere3® Consulting
Lower middle-market investor Wedbush recently announced its portfolio company, Critical Alert Systems, purchased health care software maker Sphere3.
Emergency Care Partners Merges with Progressive Emergency Physicians, Appoints Bill Yarbrough as CEO of Combined Business
A merger of two emergency department management companies with regional footprints in New York and Louisiana was backed by two lower middle-market private equity firms.
Dorilton Capital Adds New Platform, Invests in MEI Rigging & Crating
The lower middle-market investor recently announced its majority investment in moving and packaging services company MEI Rigging and Crating.
BB&T and SunTrust to Combine in Merger of Equals to Create the Premier Financial Institution
Everything you need to know about the merger of BB&T and SunTrust banks.
Frazier Healthcare Partners Launches Recida Therapeutics to Develop Novel Therapeutics for Serious Antibiotic-Resistant Infections
Frazier recently announced the launch of Recida, a biopharma company focused on developing novel therapies for antibiotic-resistant infections
Consonance Capital Partners Completes Recapitalization of Orsini Pharmaceutical Services in Partnership with Management Team
Middle-market health care investor Consonance Capital completed the recapitalization of Orsini, a specialty pharmacy focused on patients with rare diseases.